Dimensional Fund Advisors’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Buy
+62,786
New +$849K ﹤0.01% 2843
2025
Q3
Sell
-15,930
Closed -$93K 3344
2025
Q2
$93K Sell
15,930
-3,313
-17% -$19.1K ﹤0.01% 3186
2025
Q1
$126K Sell
19,243
-1,763
-8% -$11.3K ﹤0.01% 3178
2024
Q4
$130K Hold
21,006
﹤0.01% 3213
2024
Q3
$72.7K Buy
+21,006
New +$76.1K ﹤0.01% 3264
2021
Q3
Sell
-32
Closed -$113K 3532
2021
Q2
$113K Sell
32
-6
-16% -$19K ﹤0.01% 3400
2021
Q1
$115K Buy
+38
New +$136K ﹤0.01% 3340
2018
Q4
Sell
-9
Closed -$77K 3459
2018
Q3
$77K Hold
9
﹤0.01% 3375
2018
Q2
$93K Hold
9
﹤0.01% 3307
2018
Q1
$80K Buy
+9
New +$104K ﹤0.01% 3296
2017
Q1
Sell
-1
Closed -$73K 3310
2016
Q4
$73K Hold
1
﹤0.01% 3259
2016
Q3
$92K Hold
1
﹤0.01% 3235
2016
Q2
$103K Hold
1
﹤0.01% 3233
2016
Q1
$82K Hold
1
﹤0.01% 3241
2015
Q4
$132K Hold
1
﹤0.01% 3250
2015
Q3
$59K Buy
+1
New +$114K ﹤0.01% 3331

Other funds holding TENX

Dimensional Fund Advisors's TENX Position: Q1 2026 in Review

Dimensional Fund Advisors opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 62,786 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #2843 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in TENX as recently as Q2 2025.

Dimensional Fund Advisors first reported a position in TENX in Q3 2015 and has held it in 16 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Dimensional Fund Advisors held 62,786 shares of Tenax Therapeutics worth $1M as of Q1 2026.
  • Tenax Therapeutics was a new Dimensional Fund Advisors position in Q1 2026.
  • Tenax Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2843 holding.
  • Dimensional Fund Advisors first reported a position in Tenax Therapeutics in Q3 2015 and has held it in 16 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.